|
VPS36 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06930000409733E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.7968000005969E-08 |
| Normal-vs-Stage2 |
2.938100E-02 |
| Normal-vs-Stage3 |
5.761700E-03 |
| Normal-vs-Stage4 |
7.67610000007579E-07 |
| Stage1-vs-Stage2 |
8.114000E-01 |
| Stage1-vs-Stage3 |
7.606600E-01 |
| Stage1-vs-Stage4 |
2.510000E-01 |
| Stage2-vs-Stage3 |
7.215000E-01 |
| Stage2-vs-Stage4 |
2.735600E-01 |
| Stage3-vs-Stage4 |
4.678400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.27009999476513E-09 |
| Normal-vs-AfricanAmerican |
1.043460E-03 |
| Normal-vs-Asian |
3.104400E-02 |
| Caucasian-vs-AfricanAmerican |
3.027600E-01 |
| Caucasian-vs-Asian |
4.429600E-01 |
| AfricanAmerican-vs-Asian |
2.593400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.2765999913309E-09 |
| Normal-vs-Female |
1.684940E-03 |
| Male-vs-Female |
2.784000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.3540000004818E-07 |
| Normal-vs-Extreme_Weight |
1.17030000135188E-08 |
| Normal-vs-Obese |
5.599600E-04 |
| Normal-vs-Extreme_Obese |
3.291700E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.959400E-01 |
| Normal_Weight-vs-Obese |
1.311400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.019000E-01 |
| Extreme_Weight-vs-Obese |
1.188410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.641600E-01 |
| Obese-vs-Extreme_Obese |
4.697000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.14339999982505E-08 |
| Normal-vs-Age(41-60Yrs) |
1.440310E-04 |
| Normal-vs-Age(61-80Yrs) |
2.10870000350027E-08 |
| Normal-vs-Age(81-100Yrs) |
1.124590E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.490000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.237770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.768000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.008100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.397200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.84589999999252E-06 |
| Normal-VS-Type2 PRCC |
5.52129999498163E-08 |
| Normal-VS-KIRP CIMP |
3.89900334241133E-11 |
| Normal-VS-Unclassified PRCC |
5.612200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.445900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.28800000000074E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.288800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.701200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.789600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.620210E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.16930004462534E-09 |
| Normal-vs-N1 |
1.657860E-02 |
| Normal-vs-N2 |
1.66440000004542E-07 |
| N0-vs-N1 |
4.032800E-01 |
| N0-vs-N2 |
2.126600E-01 |
| N1-vs-N2 |
2.385800E-01 |
|
|
